Table 2 Patients demographics for CA2 αSN and tau burden study

n

67

34

96

M:F (% M)

40:27 (59.7%)

20:14 (58.8%)

68:28 (70.8%)

Mean age at onset (SD)

65.06 (8.75)

62.91 (11.97)

64.81 (10.49)

Mean age at death (SD)

77.34 (6.92)

76.85 (8.32)

78.03 (7.39)

Mean duration of disease (SD)

12.36 (6.38)

14.09 (6.52)

13.28 (6.44)

Mean post-mortem interval (hours)

24.67

26.56

25.15

Median Braak αSN stage

6

6

6

Median Braak tau stage

2

2

2